Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
APLS —
APELLIS PHARMACEUTICALS INC
CUSIP: 03753U106 · Held by 3 superinvestors · Combined value: $42,435,016
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $22,920,217 | 912,429 | ADD | +64,277 |
| 2 | Jim Simons | 0.0% | $15,902,417 | 633,058 | REDUCE | -89,837 |
| 3 | Ray Dalio | 0.0% | $3,612,382 | 143,805 | NEW BUY | +143,805 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +143,805 | New |
| Ken Griffin | ADD | +64,277 | +7.6% |
| Jim Simons | REDUCE | -89,837 | -12.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +711,907 | +6478.9% |
| Ken Griffin | ADD | +218,492 | +34.7% |
Who Owns APLS? Superinvestor Holdings
APELLIS PHARMACEUTICALS INC is held by 3 tracked superinvestors, with a combined position value of $42 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio), Ray Dalio (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions while 1 reduced or exited.